NEU neuren pharmaceuticals limited

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-43

  1. 1,258 Posts.
    lightbulb Created with Sketch. 311
    I believe the 4 indications they wanted to run in p11 was across the autism spectrum to not only Identify targets for p111 trials but to demonstrate broad potential of 2591 this would surely be the holy grail. If the market ever grasps the potential we could be looking at a big increase in the SP and that would be good for everyone on here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.